J Flores Soler

ORCID: 0000-0003-2037-0984
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cardiac pacing and defibrillation studies
  • Big Data and Business Intelligence
  • Healthcare Systems and Public Health
  • ECG Monitoring and Analysis
  • Business Process Modeling and Analysis
  • Physical Activity and Health
  • Cardiovascular Health and Risk Factors
  • Cardiovascular Disease and Adiposity
  • Genetic Associations and Epidemiology
  • Artificial Intelligence in Healthcare
  • Diabetes and associated disorders
  • Quality and Safety in Healthcare
  • Acute Ischemic Stroke Management
  • Long-Term Effects of COVID-19
  • Cardiovascular Function and Risk Factors
  • Wireless Body Area Networks
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • COVID-19 and healthcare impacts
  • COVID-19 and Mental Health

Hospital Clínico San Carlos
2022-2024

Universidad Complutense de Madrid
2022

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos
2021

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection causes a disease with 3% global mortality. In the absence of effective treatment, controlling risk factors that predispose to is essential reduce 2019 (COVID-19) Large observational studies suggest exercise can all-cause and disease-specific aim this study was analyze influence baseline physical activity level on COVID-19 mortality This retrospective cohort included patients between 18 70 years old, diagnosed...

10.1007/s40121-021-00418-6 article EN cc-by-nc Infectious Diseases and Therapy 2021-03-14

Abstract Introduction Atrial fibrillation (AF), a prevalent cardiac arrhythmia, often leads to an extensive array of complementary tests and treatments. While crucial for effective treatment, the frequent prescription various excessive burden on healthcare resources, resulting in prolonged waiting times potential mismanagement patient care. Addressing this challenge necessitates strategic approach understanding optimizing test prescriptions. Through lens data mining, dissect these...

10.1093/eurjpc/zwae175.130 article EN European Journal of Preventive Cardiology 2024-06-01

Abstract Introduction Cardiovascular diseases (CVDs) are a major contributor to global mortality. The early detection of cardiovascular risk factors, coupled with timely intervention strategies, is essential for CVD prevention. PreveCardio was developed as an innovative, single-visit population screening model designed facilitate the identification and management factors within 1 million in European capital city region totaling 6 inhabitants. Purpose This study aimed ascertain prevalence...

10.1093/eurheartj/ehae666.3606 article EN European Heart Journal 2024-10-01

Abstract Introduction and purpose Atrial fibrillation (AF) is the most common arrhythmia worldwide, with a considerable prevalence, high morbidity, mortality, finantial cost in Europe. To optimise quality of medical care received patients AF, we need to know investigate their accurate demographic clinical typology actual patient journey, which involves many data review number included. The CHA2DS2Vasc score classifies risk stroke atrial fibrillation, one critical complications this...

10.1093/ehjdh/ztac076.2792 article EN cc-by-nc European Heart Journal - Digital Health 2022-12-22

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Many patients with heart failure (HF) suffer from decompensation that sometimes leads to hospitalizations, harming prognosis and quality life. Some cardiac implantable electronic devices (CIEDs) allow the transmission clinical data online, providing helpful information without patient having go a face-to-face consultation, which usually takes no less than 25 minutes. Moreover, 5-variable multiparametric tool (S1 S3...

10.1093/eurjpc/zwad125.338 article EN European Journal of Preventive Cardiology 2023-05-24

Abstract Introduction Heart failure (HF) is the leading cause of cardiovascular hospitalisation in developed countries. More and more HF patients are receiving cardiac implantable electronic devices (CIED) that collect physiological data may be used to predict decompensations avoid through early medical interventions. Some CIEDs have a Multiparameter heart index (HF-I), which an algorithm based on information provided by five sensors (heart sounds, respiration, chest impedance, rate activity...

10.1093/eurheartj/ehad655.2975 article EN European Heart Journal 2023-11-01

Background: The 9p21 region is the most relevant locus associated with coronary heart disease in different populations. However, there are no studies that prove this a risk factor Venezuelan population. Objectives: To analyze whether or not rs1333049 polymorphism for acute myocardial infarction (AMI) patients, as well to investigate its correlation cardiovascular factors (CVRF), age of occurrence, type and severity infarction, [...]

10.36660/ijcs.20200404 article EN cc-by International Journal of Cardiovascular Sciences 2022-02-11

Abstract Funding Acknowledgements Type of funding sources: None. Introduction Follow-up in patients with cardiovascular implantable electronic devices (CIED) is essential to avoid adverse events and complications, such as arrhythmias, device dysfunction, infections, among other events. Prevention plays a fundamental role, especially when these undergo non-cardiological invasive tests and/or procedures (e.g., surgeries) or magnetic resonance imaging (MRI). These situations sometimes require...

10.1093/eurjpc/zwac056.300 article EN European Journal of Preventive Cardiology 2022-05-01

Abstract Introduction and purpose Atrial fibrillation (AF) is the most common arrhythmia worldwide, with a considerable prevalence, high morbidity, mortality, finantial cost in Europe. To optimise quality of medical care received patients AF, we need to know investigate their accurate demographic clinical typology actual patient journey, which involves many data review number included. The CHA2DS2Vasc score classifies risk stroke atrial fibrillation, one critical complications this...

10.1093/eurheartj/ehac544.2792 article EN European Heart Journal 2022-10-01
Coming Soon ...